Risk Factors for Long-Term Complications and Quality of Life after HCT
Risk Factors for Long-Term Complications and Quality of Life after HCT
Track: BMT Tandem "Scientific" Meeting
Friday, February 28, 2014, 8:30 AM-10:00 AM
Texas B+D (Gaylord Texan)
Disclosures:
J. R. Wingard,
Astellas, consultant in design of vaccine trial: Consultancy
Pfizer, speaker: Honoraria
NERI, Data review committee: Consultancy
UpToDate, writer of articles: Royalty
Pfizer, speaker: Honoraria
NERI, Data review committee: Consultancy
UpToDate, writer of articles: Royalty
See more of: Survivorship Care and Long-Term Complications after HCT
See more of: BMT Tandem "Scientific" Meeting
See more of: BMT Tandem "Scientific" Meeting
<< Previous Presentation
|
Next Presentation